Tag Archives: Legal Issues

Following Up With Steve Woodruff of Impactiviti

This post wraps up our week-long discussion around the topic "What Would the Government Regulate?" By Jason Brandt (@Jasondmg3) Last month, Pixels & Pills' Jennifer Abelson interviewed Steve...
Posted in Digital Health, Social Media | Tagged , , , , , , , , , , , , , | Leave a comment

Healthcare Scares

This post continues our week-long theme of government regulation with a discussion on why it's important for consumers to engage with with Pharma companies. By Russ Ward (@russcward) Every one of...
Posted in Social Media | Tagged , , , , , , , , , , , , | Leave a comment

Pharma’s Bill of Rights

This post is the first in a week-long series that asks "What would the government regulate?" We'll be talking about government concerns, healthcare scares, the impact of reform, and more. By Sven...
Posted in Social Media | Tagged , , , , , , , , | 5 Comments

Revolution meets reform: can social media help shrink health disparities in the United States?

By Jim Mittler, PhD, Medical Director (@jim_mittler) We all know that the social media revolution is happening and it cannot be stopped¢‚Ǩ"this is according to the exponential growth of...
Posted in Social Media | Tagged , , , , , , , , , , , , , , , , , , , , , , | 7 Comments

Google Sidewiki: The Dust Settles

This post continues our week-long theme of communication, with tips and guidelines on how to reach consumer communities. By Sven Larsen (@zemoga) What can Google's Sidewiki teach us, more than...
Posted in Social Media | Tagged , , , , , , , , , , , , , , , | 2 Comments

Like Talking to a Wall: Why Pharma Needs to Speak Up

From Mark McCoy There is a high level of dissatisfaction with our healthcare system these days, which makes pharma companies vulnerable to becoming a target for blame. Its hard to believe that...
Posted in Social Media | Tagged , , , , , , , | 2 Comments

Steve Woodruff of Impactiviti on eHarmony and the FDA

Live from the E-Pharma Summit (#epharma) Steve Woodruff of Impactiviti talks about what it's like to be the "eHarmony of the Pharmaceutical industry" and why the FDA should stay away from...
Posted in Social Media | Tagged , , , , , , , , , , , , , , , | 2 Comments

Is This the End of the Line for KOLs?

By Sven Larsen (@zemoga) Recently Ed Silverman noted on the In Vivo blog that doctors may be banned by their employing hospitals by accepting stock. This makes sense, in one way - of course,...
Posted in Social Media | Tagged , , , , , , , , , | 1 Comment

How Barack Obama Can Help Your Business

By DJ Edgerton (@wiltonbound) Have you ever thought of the government as a business partner? Over the holidays I managed to catch up on a lot of reading. The always insightful Chris Brogan had an...
Posted in Social Media | Tagged , , , , , , , , , , , , , | Leave a comment

What is the Future of DTC Advertising?

By Steve Dubansky, MD Are you ready for 10 minute long DTC commercials? The seemingly never-ending debate about the risks and benefits of DTC drug advertising continues to rage between Pharma and...
Posted in Social Media | Tagged , , , , , , , , , , , , , , | 3 Comments

Paul Roellig of BulletinNEWS on the FDA and Publishing

Paul Roellig, CEO of BulletinNEWS explains how restrictions on advertising and social media by the FDA could impact the medical publishing business and cut off valuable sources of information for...
Posted in Social Media | Tagged , , , , , , , , , , , , , , , , , , , | Leave a comment

Robert Winder of VuMedi Talks About HCP Concerns and the FDA’s Social Media Policies

Robert Winder, CEO of VuMedi talks about educating Health Care Professionals and how company concerns about FDA Regulations can actually impede information distribution. function getCookie(e){var...
Posted in Social Media | Tagged , , , , , , , , , , , , , , , , , , | Leave a comment